Ontology highlight
ABSTRACT:
SUBMITTER: Park MC
PROVIDER: S-EPMC6528252 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
Park Min-Chan MC Matsuno Hiroaki H Kim Jinseok J Park Sung-Hwan SH Lee Sang-Heon SH Park Yong-Beom YB Lee Yun Jong YJ Lee Sang-Il SI Park Won W Sheen Dong Hyuk DH Choe Jung-Yoon JY Choi Chan-Bum CB Hong Seung-Jae SJ Suh Chang-Hee CH Lee Shin-Seok SS Cha Hoon-Suk HS Yoo Bin B Hur Jin-Wuk JW Kim Geun-Tae GT Yoo Wan-Hee WH Baek Han Joo HJ Shin Kichul K Shim Seung Cheol SC Yang Hyung-In HI Kim Hyun Ah HA Park Kyung-Su KS Choi In Ah IA Lee Jisoo J Tomomitsu Masato M Shin Seonghye S Lee Jiyoon J Song Yeong Wook YW
Arthritis research & therapy 20190521 1
<h4>Background</h4>To evaluate the long-term efficacy, safety and immunogenicity of continuing LBEC0101; the etanercept (ETN) biosimilar; or switching from the ETN reference product (RP) to LBEC0101 in patients with rheumatoid arthritis (RA).<h4>Methods</h4>This multicentre, single-arm, open-label extension study enrolled patients who had completed a 52-week randomised, double-blind, parallel phase III trial of LBEC0101 vs ETN-RP. Patients treated with ETN-RP during the randomised controlled tri ...[more]